| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-08 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.2 | 8e-07 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.12 | 5e-05 |